CLINICAL_TRIALS
trial_result
· 2006-08-01
Clinical Trial Update: Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV [Phase 2]
Summary
Phase 2 clinical trial update on using tenofovir disoproxil fumarate to prevent HIV infection. The study status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: FHI 360 | Conditions: HIV Infections | Phase 2 | Status: COMPLETED